FindTrial
Sign In

intravenous immunoglobulins

DRUG7 trials

Sponsors

Prothya Biosolutions, University of Giessen, Centre Hospitalier Universitaire de Besancon, Azienda Ospedaliera Universitaria Integrata Verona, Assistance Publique - Hôpitaux de Paris

Conditions

Complex Regional Pain Syndrome Type 1IgG DeficiencyImmune Thrombocytopenia (ITP)InfectionsMyocardial DiseasesParvovirus B19, HumanPost-polio SyndromeSolar Urticaria

Phase 2

Intravenous Immunoglobulins in Severe and Refractory Solar Urticaria
CompletedNCT01360658
Centre Hospitalier Universitaire de BesanconSolar Urticaria
Start: 2011-06-30End: 2013-06-30Updated: 2013-07-30
Intravenous immunoglobulins as early treatment in newly diagnosed idiopathic inflammatory myopathies (IMMEDIATE): a pilot study.
Active, not recruitingNL-OMON46904
Academisch Medisch Centrummuscle inflammation myositis
Start: 2017-04-06Target: 20Updated: 2024-02-28

Phase 3

Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy
CompletedNCT00892112
Prothya BiosolutionsMyocardial Diseases, Parvovirus B19, Human
Start: 2009-11-30End: 2018-06-30Updated: 2018-08-29
Intravenous Immunoglobulins in Complex-regional Pain Syndrome
WithdrawnNCT00949065
University of GiessenComplex Regional Pain Syndrome Type 1
Start: 2009-08-31End: 2011-02-15Updated: 2021-07-15
Intravenous Immunoglobulins for Post-Polio Syndrome
CompletedNCT01537575
Azienda Ospedaliera Universitaria Integrata VeronaPost-polio Syndrome
Start: 2008-01-31Updated: 2012-02-27
IgIV Plus Prednisone vs High-dose Dexamethasone for ITP
RecruitingNCT04968899
Assistance Publique - Hôpitaux de ParisImmune Thrombocytopenia (ITP)
Start: 2022-04-07End: 2026-10-09Target: 272Updated: 2023-09-11

Phase 4

Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response
CompletedNCT00522821
Prothya BiosolutionsIgG Deficiency, Infections
Start: 2007-11-30End: 2014-07-31Updated: 2015-04-06

Related Papers

Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus <scp>B19</scp> persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial
European Journal of Heart Failure2020-12-2235 citations